Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase 3b Study of Vernakalant Injection in Patients With Recent Onset Symptomatic Atrial Fibrillation (AF)(MK-6621-045) (ACT V)
This study has been terminated.
Study NCT00989001   Information provided by Cardiome Pharma

First Received on October 1, 2009.   Last Updated on February 6, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial